(Q34426559)

2 August 2017

title

Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity (English)

1 reference

2 August 2017

1 reference

1 reference

Mateo C

1 reference

2 August 2017

Moreno E

1 reference

2 August 2017

Amour K

1 reference

2 August 2017

Lombardero J

1 reference

2 August 2017

Harris W

1 reference

2 August 2017

Pérez R

1 reference

2 August 2017

publication date

1 March 1997

1 reference

Immunotechnology : an international journal of immunological engineering

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

71-81

1 reference

Epidermal growth factor receptors in human breast cancer

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

mRNA expression of transforming growth factor alpha in human breast carcinomas and its activity in effusions of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

The epidermal growth factor receptor as a target for therapy in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Conformations of immunoglobulin hypervariable regions

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Antibody framework residues affecting the conformation of the hypervariable loops

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Anatomy of the antibody molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

A new monoclonal antibody for detection of EGF-receptors in western blots and paraffin-embedded tissue sections

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36-71. 1. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Conformational sampling using high-temperature molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Humanization of a mouse monoclonal antibody by CDR–grafting: the importance of framework residues on loop conformation

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

Structure, function and properties of antibody binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2897%2900065-1

7 January 2021

10.1016/S1380-2933(97)00065-1

Identifiers

DOI

1 reference

2 August 2017

1 reference